Evidence map›Paper›PMID 37125534›Full record

ReviewStroke2023

Cognitive Impairment After Ischemic and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association/American Stroke Association.

Nada El Husseini, Irene L Katzan, Natalia S Rost, Margaret Lehman Blake, Eeeseung Byun, Sarah T Pendlebury, Hugo J Aparicio, María J Marquine, Rebecca F Gottesman, Eric E Smith and 1 more

4 registry-linked trialsOpen access · bronzeAbstract readReview
In one paragraph

Review in Stroke, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 313 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
313citing papers in PubMed, 10 pooled it
104.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06615973 recruitingnot on this mapstarted 2026, after this paper: background citation

Understanding Stroke Outcomes: Stroke Resilience, Infarct Burden, and Long-Term Cognition

TypeobservationalSponsorNational Institute of Neurological Disorders and Stroke (NINDS)Ran2026 to 2027Enrolled450ConditionsStroke, Brain Disease, Vascular Diseases, Cerebrovascular Disorder
NCT07220538 phase4recruitingnot on this mapstarted 2025, after this paper: background citation

Pragmatic Open-label, Parallel-group Clinical Trial on the Effectiveness of Extract of Ginkgo Biloba Leaves Tablets as add-on to Standard of Care in Participants With Cognitive Impairment After an Acute Ischemic Stroke (GiCIIS)

TypeinterventionalSponsorDr. Willmar Schwabe GmbH & Co. KGRan2025 to 2027Enrolled400ConditionsIschemic Stroke Hospitalized, Impairment, CognitiveArmsExtract of Ginkgo Biloba Leaves Tablets 240 mg (2 x 40 mg, t.i.d.), Standard of care (SoC) Group
NCT07588997 narecruitingnot on this mapstarted 2025, after this paper: background citation

The Efficacy of Early Motor-Cognitive Integrative Training on Cognitive and Motor Performance in Patients With Aneurysmal Subarachnoid Hemorrhage

TypeinterventionalSponsorNational Taiwan University HospitalRan2025 to 2027Enrolled18ConditionsSubarachnoid Aneurysm HemorrhageArmsearly motor-cognitive integrated training (e-MCIT), Early mobilization
NCT07761182 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Cognitive Outcomes in Patients With Branch Atheromatous Disease-Related Stroke: A Prospective Cohort Study

TypeobservationalSponsorPeking Union Medical College HospitalRan2026 to 2028Enrolled60ConditionsBranch Atheromatous Disease, Cognitive, Deterioration, ClinicalArmsEND exposure
3 · Its place in the literature

Who cites it

313 citing papers in PubMed, 10 syntheses or guidelines pooled it, 403 citations in OpenAlex.

  1. Pooled it
  2. Exercise effects on cognitive function and molecular markers in post-stroke patients with cognitive impairment: a systematic review and meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

253 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Nada El Husseini
Irene L Katzan
Natalia S Rost
Margaret Lehman Blake
Eeeseung Byun
Sarah T Pendlebury
Hugo J Aparicio
María J Marquine
Rebecca F Gottesman
Eric E Smith
American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; Council on Hypertension; and Council on Lifestyle and Cardiometabolic Health
Kadlec Clinic · USLaboratoire de Physique des 2 Infinis Irène Joliot-Curie · FRSmith Family · AU

Funding

Stroke, Cognition and Neuroepidemiology SectionZIANS009435 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI GOTTESMAN, REBECCA F · 2022 to 2025
$8.2M
Research and Mentoring on Neurocognitive Disparities in AgingK24AG075240 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Maria Marquine · 2022 to 2026
$1.1M
Mechanisms of Symptoms in Subarachnoid Hemorrhage: Sleep Disturbance, Fatigue and Impaired CognitionK23NR017404 · NINR · UNIVERSITY OF WASHINGTON · PI BYUN, EEESEUNG · 2017 to 2019
$437k
NIA NIH HHS K24 AG075240NINR NIH HHS K23 NR017404
6 · The paper itself

Abstract

purposeCognitive impairment is a common consequence of stroke and has direct implications for poststroke functioning and quality of life, including the ability to maintain a job, live independently, sustain interpersonal relationships, and drive a vehicle. In this scientific statement, we critically appraise the literature on the prevalence, diagnosis, and management of poststroke cognitive impairment (PSCI) and provide a framework for clinical care while highlighting gaps that merit further study.

methodsWe performed a scoping literature review of randomized controlled clinical trials, prospective and retrospective cohort studies, case-control studies, clinical guidelines, review articles, and editorials on the incidence and prevalence, natural history, diagnosis, and management of PSCI. Scoping reviews determine the scope of a body of literature on a given topic to indicate the volume of literature and the studies currently available and provide an overview of its focus.

resultsPSCI is common after stroke, especially in the first year, and ranges from mild to severe. Although cognitive impairment is reversible in some cases early after stroke, up to one-third of individuals with stroke develop dementia within 5 years. The pathophysiology is not yet fully elucidated but is likely attributable to an acute stroke precipitating a series of pathological events, often in the setting of preexisting microvascular and neurodegenerative changes. Screening for associated comorbidities and interdisciplinary management are integral components of the care of individuals with PSCI. There is a need for prospective studies evaluating the individual trajectory of PSCI and the role of the acute vascular event in the predisposition for Alzheimer disease and related dementias, as well as high-quality, randomized clinical trials focused on PSCI management.

Indexed as

Cognitive DysfunctionHemorrhagic StrokeStrokeAmerican Heart AssociationHumansProspective StudiesQuality of LifeRetrospective StudiesAHA Scientific Statementscognitive dysfunctiondepressionprevalenceprospective studiesrisk factorsstroke

Identifiers

PMID37125534
PMCPMC12723706
OpenAlexW4367601115

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.